Esperion Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Esperion Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.3M | 1.2M | 2.65 |
| 2025-06-30 | $1.5M | 1.5M | 0.98 |
| 2025-03-31 | $965k | 670k | 1.44 |
| 2024-12-31 | $1.9M | 877k | 2.20 |
| 2024-09-30 | $149k | 90k | 1.65 |
| 2024-06-30 | $151k | 68k | 2.22 |
| 2024-03-31 | $57k | 21k | 2.68 |
| 2023-12-31 | $706k | 236k | 2.99 |
| 2023-09-30 | $31k | 31k | 0.98 |
| 2023-06-30 | $77k | 55k | 1.39 |
| 2023-03-31 | $101k | 64k | 1.59 |
| 2022-12-31 | $146k | 24k | 6.23 |
| 2022-09-30 | $108k | 14k | 7.65 |
| 2022-06-30 | $102k | 17k | 6.22 |
| 2022-03-31 | $64k | 14k | 4.62 |
| 2021-12-31 | $322k | 65k | 4.97 |
| 2021-09-30 | $415k | 35k | 12.03 |
| 2021-06-30 | $1.1M | 53k | 21.16 |
| 2021-03-31 | $1.9M | 67k | 28.05 |
| 2020-12-31 | $371k | 14k | 25.98 |
| 2020-09-30 | $875k | 24k | 37.16 |
| 2020-06-30 | $2.9M | 56k | 51.31 |
| 2020-03-31 | $4.3M | 136k | 31.54 |
| 2019-12-31 | $3.9M | 65k | 59.65 |
| 2019-09-30 | $0 | 11k | 0.00 |
| 2019-06-30 | $1.2M | 25k | 46.52 |
| 2019-03-31 | $997k | 25k | 40.17 |
| 2018-12-31 | $8.5M | 185k | 46.01 |
| 2018-09-30 | $3.1M | 71k | 44.35 |
| 2018-06-30 | $1.6M | 40k | 39.19 |
| 2018-03-31 | $8.0M | 111k | 72.33 |
| 2017-12-31 | $5.5M | 84k | 65.83 |
| 2017-09-30 | $5.2M | 104k | 50.13 |
| 2017-06-30 | $7.0M | 152k | 46.28 |
| 2017-03-31 | $3.6M | 101k | 35.31 |
| 2016-12-31 | $607k | 48k | 12.53 |
| 2016-09-30 | $684k | 49k | 13.85 |
| 2016-06-30 | $141k | 14k | 10.00 |
| 2016-03-31 | $169k | 11k | 15.00 |
| 2015-12-31 | $3.2M | 143k | 22.26 |
| 2015-09-30 | $1.5M | 63k | 23.60 |
| 2015-03-31 | $59k | 623 | 95.00 |